Status:
COMPLETED
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
Lead Sponsor:
Allergan
Conditions:
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).
Eligibility Criteria
Inclusion
- Diagnosis of DME in at least one eye treated OZURDEX® per clinical practice
Exclusion
- None
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02188173
Start Date
July 1 2014
End Date
May 1 2016
Last Update
June 1 2016
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Retinal Consultants of Phoenix
Phoenix, Arizona, United States, 85014
2
West Coast Retina
San Francisco, California, United States, 94109
3
Orange Co Retina Medical Group
Santa Ana, California, United States, 92705
4
Bay Area Retina Associates
Walnut Creek, California, United States, 94598